<DOC>
	<DOCNO>NCT01737216</DOCNO>
	<brief_summary>Pilot study Zoledronic acid combination first-line chemotherapy age patient lung cancer . The purpose assess effect Zoledronic acid combination first-line chemotherapy age patient lung cancer bone mineral density gain lumbar spine total hip .</brief_summary>
	<brief_title>Pilot Study Zoledronic Acid Combination With First-line Chemotherapy Aged Patients With Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Signed informed consent form Age â‰¥70 year Performance Status Eastern Cooperative Oncology Group ( ECOG ) 01 Histologically cytologically confirm lung cancer Did receive bisphosphonate treatment Appear relapse metastasis receive bisphosphonate treatment Active uncontrolled infection Pregnant lactating woman</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Aged</keyword>
	<keyword>patient</keyword>
</DOC>